Table2. Comparison of different mode of labor |
Table2.
Comparison of different mode of labor |
Table2. Comparison of
different mode of labor |
Table2. Comparison of different mode
of labor |
Table2. Comparison of different mode of labor |
Table2. Comparison of different mode of labor |
Table2.
Comparison of different mode of labor |
Table2. Comparison of
different mode of labor |
Table2. Comparison of different mode
of labor |
Table2. Comparison of different mode of
labor |
Mode |
40 0/7 to 40 6/7w |
40 0/7 to 40 6/7w |
41 0/7 to 41 6/7w |
41 0/7 to 41 6/7w |
P-value |
P-value |
T/X2 |
T/X2 |
T/X2 |
|
N=1107 |
N=1107 |
N=462 |
N=462 |
|
|
|
|
|
Spontaneous labor–no. (%) |
597 (54) |
597 (54) |
94 (20) |
94 (20) |
0.000* |
0.000* |
149.17 |
149.17 |
149.17 |
BCCO–no. (%) |
100 (9) |
100 (9) |
212 (46) |
212 (46) |
0.000* |
0.000* |
277.90 |
277.90 |
277.90 |
Bishop score |
3.07±1.30 |
3.07±1.30 |
2.77±1.28 |
2.77±1.28 |
0.055 |
0.055 |
1.93 |
1.93 |
1.93 |
Vaginal delivery–no. (%) |
88 (88) |
88 (88) |
167 (79) |
167 (79) |
0.049* |
0.049* |
3.87 |
3.87 |
3.87 |
Oxytocin–no. (%) |
239 (22) |
239 (22) |
127 (27) |
127 (27) |
0.012* |
0.012* |
6.34 |
6.34 |
6.34 |
Vaginal delivery–no. (%) |
191 (80) |
191 (80) |
97 (76) |
97 (76) |
0.431 |
0.431 |
0.62 |
0.62 |
0.62 |
AROM–no. (%) |
238 (21) |
238 (21) |
143 (31) |
143 (31) |
0.000* |
0.000* |
15.84 |
15.84 |
15.84 |
Vaginal delivery–no. (%) |
198 (83) |
198 (83) |
102 (71) |
102 (71) |
0.006* |
0.006* |
7.51 |
7.51 |
7.51 |
mesns significant difference between groups; BCCO: balloon catheter
combined with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
*mesns
significant difference between groups; BCCO: balloon catheter combined
with oxytocin, AROM: artificial rupture of membranes |
Table3. Maternal outcomes in two groups |
Table3.
Maternal outcomes in two groups |
Table3. Maternal outcomes in
two groups |
Table3. Maternal outcomes in two groups |
Table3. Maternal outcomes in two groups |
Table3.
Maternal outcomes in two groups |
Table3. Maternal outcomes in
two groups |
Table3. Maternal outcomes in two groups |
Table3. Maternal outcomes in two groups |
|
Outcomes |
Outcomes |
40 0/7 to 40 6/7 w |
40 0/7 to 40 6/7 w |
41 0/7 to 41 6/7 w |
41
0/7 to 41 6/7 w |
P-value |
P-value |
T/X2 |
|
|
|
N=1107 |
N=1107 |
N=462 |
N=462 |
|
|
|
|
Vaginal delivery–no. (%) |
Vaginal delivery–no. (%) |
999 (90) |
999 (90) |
369 (80) |
369 (80) |
0.000* |
0.000* |
31.41 |
|
Instrumental delivery–no. (%) |
Instrumental delivery–no. (%) |
9 (0.8) |
9 (0.8) |
7 (1.9) |
7 (1.9) |
0.216 |
0.216 |
1.53 |
|
Episiotomy–no. (%) |
Episiotomy–no. (%) |
408 (41) |
408 (41) |
179 (49) |
179 (49) |
0.011* |
0.011* |
6.47 |
|
ICS–no./total no. (%) |
ICS–no./total no. (%) |
108/1304 (8) |
108/1304 (8) |
93/564 (16) |
93/564 (16) |
0.000* |
0.000* |
27.62 |
|
Cephalopelvic disproportion–no. (%) |
Cephalopelvic
disproportion–no. (%) |
67 (6) |
67 (6) |
46 (10) |
46 (10) |
0.073 |
0.073 |
3.21 |
|
Fetal distress–no. (%) |
Fetal distress–no. (%) |
31 (29) |
31
(29) |
36 (39) |
36 (39) |
0.133 |
0.133 |
2.25 |
|
Postpartum hemorrhage/ml–no. (%) |
Postpartum hemorrhage/ml–no.
(%) |
158 (14) |
158 (14) |
77 (17) |
77 (17) |
0.226 |
0.226 |
1.47 |
|
500-999–no. (%) |
500-999–no. (%) |
113 (10) |
113 (10) |
52
(11) |
52 (11) |
0.538 |
0.538 |
0.38 |
|
≥ 1000–no. (%) |
≥ 1000–no. (%) |
45 (4) |
45 (4) |
25 (5) |
25
(5) |
0.239 |
0.239 |
1.39 |
|
Epidural analgesia–no. (%) |
Epidural analgesia–no. (%) |
842
(76) |
842 (76) |
374 (81) |
374 (81) |
0.034* |
0.034* |
4.47 |
|
Shoulder dystocia–no. (%) |
Shoulder dystocia–no. (%) |
4 (0.4) |
4 (0.4) |
1 (0.2) |
1 (0.2) |
1.000 |
1.000 |
0.00 |
|
MSAF–no. (%) |
MSAF–no. (%) |
146 (13) |
146 (13) |
87 (19) |
87
(19) |
0.004* |
0.004* |
8.21 |
|
OASIS–no. (%) |
OASIS–no. (%) |
0 |
0 |
0 |
0 |
- |
- |
|
|
Intrapartum cervical laceration–no. (%) |
Intrapartum cervical
laceration–no. (%) |
5 (0.5) |
5 (0.5) |
2 (0.4) |
2 (0.4) |
1.000 |
1.000 |
0.00 |
|
Amniotic fluid embolism–no. (%) |
Amniotic fluid embolism–no.
(%) |
1 (0.1) |
1 (0.1) |
0 |
0 |
1.000 |
1.000 |
0.00 |
|
Labor duration in nullipara /h |
Labor duration in nullipara /h |
Labor
duration in nullipara /h |
Labor duration in nullipara /h |
Labor
duration in nullipara /h |
Labor duration in nullipara /h |
Labor
duration in nullipara /h |
Labor duration in nullipara /h |
Labor
duration in nullipara /h |
|
The first stage (analgesia) |
The first stage (analgesia) |
10.4±3.4 |
10.4±3.4 |
10.9±3.2 |
10.9±3.2 |
0.054Τ
|
0.054Τ
|
-1.93 |
|
The second stage(analgesia) |
The second stage(analgesia) |
1.3±0.7 |
1.3±0.7 |
1.3±0.8 |
1.3±0.8 |
0.107Τ
|
0.107Τ
|
-1.61 |
|
The first stage (non-analgesia) |
The first stage (non-analgesia) |
7.9±3.5 |
7.9±3.5 |
8.6±3.7 |
8.6±3.7 |
0.275Τ
|
0.275Τ
|
-1.10 |
|
The second stage (non-analgesia) |
The second stage (non-analgesia) |
1.0±0.6 |
1.0±0.6 |
1.1±0.6 |
1.1±0.6 |
0.365Τ
|
0.365Τ
|
-0.91 |
|
Labor duration in multipara/h |
Labor duration in multipara/h |
Labor
duration in multipara/h |
Labor duration in multipara/h |
Labor duration
in multipara/h |
Labor duration in multipara/h |
Labor duration in
multipara/h |
Labor duration in multipara/h |
Labor duration in
multipara/h |
|
The first stage (analgesia) |
The first stage (analgesia) |
6.2±2.5 |
6.2±2.5 |
6.6±2.9 |
6.6±2.9 |
0.335Τ
|
0.335Τ
|
-0.97 |
|
The second stage (analgesia) |
The second stage (analgesia) |
0.5±0.4 |
0.5±0.4 |
0.5±0.4 |
0.5±0.4 |
0.368Τ
|
0.368Τ
|
-0.90 |
|
The first stage(non-analgesia) |
The first stage(non-analgesia) |
4.5±1.9 |
4.5±1.9 |
5.0±2.3 |
5.0±2.3 |
0.228Τ
|
0.228Τ
|
-1.21 |
|
The second stage (non-analgesia) |
The second stage (non-analgesia) |
0.3±0.3 |
0.3±0.3 |
0.5±0.5 |
0.5±0.5 |
0.097Τ
|
0.097Τ
|
-1.70 |
|
mesns significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter injury |
*mesns
significant difference between groups; Τone-way
analysis of variance; ICS: intrapartum cesarean section; MSAF: meconium
stained amniotic fluid; OASIS: obstetric anal sphincter
injury |
|